Kuopion yliopistollinen sairaala
Kuopio University Hospital

Julkaisut 2008
Publications 2008

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Alafuzoff I et al. Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium.
2 Alafuzoff I et al. Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe consortium.
3 Alafuzoff I et al. Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium.
4 Aarnisalo J et al. Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant.
5 Aarnisalo J et al. Cytomegalovirus infektion in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes.
6 Aggarwal NT et al. Endothelial 15-lipoxygenase-1 overexpression increases acetylcholine-induced hypotension and vasorelaxation in rabbits.
7 Aho L et al. Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects.
8 Ahonen J. Miksi kodeiini, tramadoli tai etyylimorfiini ei aina tehoa?
9 Ahonen TM et al. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein.
10 Ahtoniemi T et al. Mutant SOD1 from spinal cord of G93A rats is destabilized and binds to inner mitochondrial membrane.
11 Ahvenainen T et al. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer.
12 Aittoniemi J et al. Relation among mannose-binding lectin 2 genotype, B-cell autoantibodies, and risk for type 1 diabetes in Finnish children.
13 Alafuzoff I. Cerebral amyloid angiopathy, hemorrhages and superficial siderosis.
14 Annola K et al. Transplacental transfer of acrylamide and glycidamide are comparable to that of antipyrine in perfused human placenta.
15 Antikainen R. Vuorovaikutuksen regressiiviset ilmiöt hoitosuhdetyöskentelyn kompastuskivinä.
16 Antikainen R, Ranta M. Kohti vastavuoroisuutta. Psykoterapeuttinen hoitosuhde.
17 Arokoski J et al. Glukosamiini nivelrikon hoidossa.
18 Arokoski J et al. Nivelrikon lääkehoito.
19 Backman T et al. Onko pitkäaikainen hormonaalinen ehkäisy turvallista?
20 Bakris G et al. Cardiovascular protection for all individuals at high risk: evidence-based best practice.
21 Balkau B et al. Physical activity and insulin sensitivity: the RISC Study.
22 Bell JE et al. Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.
23 Bellmunt J et al. Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
24 Bello IO et al. Expression of claudins 1, 4, 5, and 7 and occludin, and reletionship with prognosis in squamous cell carcinoma of the tongue.
25 Bendel P et al. MR imaging of the brain 1 year after aneurysmal subaracbnoid hemorrhage. Randomized study comaparing surgical with endovascular treatment.
26 Bendel S et al. Free cortisol in sepsis and septic shock.
27 Bendel S et al. Pituitary-adrenal function in patients with acute subarachnoid haemorrhage: a prospective cohort study.
28 Benest AV et al. VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis.
29 Berg M et al. Evidence-based care and childbearing - a critical approach.
30 Bergamaschi A et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
31 Berlac P et al. Pre-hospital airway management: guidelines from a task force from the Scandinavian Society for Anaesthesiology and Intensive Care Medicine.
32 Berthold HK et al. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
33 Bertram L et al. No association between CALHM1 and Alzheimers's disease risk.
34 Bhardwaj S et al. Gene therapy to prevent occlusion of venous bypass grafts.
35 Bilguvar K et al. Susceptibility loci for intracranial aneurysm in European and Japanese populations.
36 Blom ES et al. Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease.
37 Boesgaard TW et al. The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients - the EUGENE2 study.
38 Bonnet F et al. Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects.
39 Botusan IR et al. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice.
40 Califf RM et al. Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
41 Casalini P et al. Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact.
42 Castaneda AE et al. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults.
43 Chen W-M et al. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.
44 Chibalin AV et al. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance.
45 Danner N et al. Navigated transcranial magnetic stimulation and computed electric field strength reduce stimulator-dependent differences in the motor threshold.
46 De Mello V et al. Downregulation of genes involved in NFkappaB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study.
47 de Mello VDF et al. Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome.
48 Delanghe JR et al. Trueness verification of actual creatinine assays in the European market demonstrates a disappointing variability that needs substantial improvement. An international study in the framework of the EC4 creatinine standardization working group.
49 Diaconu N-C et al. Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysis.
50 Dworakowski R et al. Experimental hyperlipidaemia does not prevent preconditioning and it reduces ischemia-induced apoptosis.
51 Ege MJ et al. Specific IgE to allergens in cord blood is associated with maternal immunity to Toxoplasma gondii and rubella virus.
52 Ellrichmann M et al. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecytokinin, and peptide YY concentrations.
53 Elovaara I et al. Immunologinen lääkehoito MS-taudin eri vaiheissa.
54 Endres M et al. Improving outcome after stroke: Overcoming the translational roadblock.
55 Eriksson K et al. Hoitotiede ja tiede-etiikka.
56 Erkkilä A et al. Dietary fatty acids and cardiovascular disease: an epidemiological approach.
57 Erkkilä AT et al. Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications.
58 Erkko H et al. Penetrance analysis of the PALB2 c.1592delT founder mutation.
59 Ervasti M. Evaluation of Iron Status Using Methods on the Features of Red Blood Cells and Reticulocytes.
60 Ervasti M et al. Elevated serum erythropoietin concentration is associated with coordinated changes in red blood cell and reticulocyte indices of pregnant women at term.
61 Ervasti M et al. Diagnostic, clinical and laboratory turnaround times in troponin T testing.
62 Ervasti M et al. Novel red cell indices indicating reduced availability of iron are associated with high erythropoietin concentration and low pH level in the venous cord blood of newborns.
63 Eskelinen MH et al. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study.
64 Euling SY et al. Examination of US puberty-timing data from 1940 to 1994 for secular trends: Panel findings.
65 Fagerholm R et al. NAD(P)H:quinone oxidoreductase 1 NQ01*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
66 Fagerholm V et al. Autoradiographic characterization of alpha 2C-adrenoceptors in the human striatum.
67 Fledderus JO et al. KLF2 primes the antioxidant transcription factor Nrf2 for activation in endothelial cells.
68 Forestier E et al. Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;qI1.2)-positive B-cell precursor acute lymphoblastic leukemias: A Nordic series of 24 cases and review of the literature.
69 Forestier E et al. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
70 Friedrich B et al. Variance of the SGK1 gene is associated with insulin secretion in different European populations: results from the TUEF, EUGENE2, AND METSIM studies.
71 Fröjd SA et al. Depression and school performance in middle adolescent boys and girls.
72 Garcia-Closas M et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
73 Geirsson RT, Heinonen S. Springing to life.
74 Geirsson RT, Heinonen S. Donors, diet and laparoscopic dissection.
75 Goldstein LB et al. Relative effects of statin therapy on stroke and cardiovascular events in men and women. Secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study.
76 Goldsteins G et al. Deleterious role of superoxide dismutase in the mitochondrial intermembrane space.
77 Gouni-Berthold I et al. Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men.
78 Grönroos MH et al. Long-term follow-up of renal function after high-dose methotrexate treatment in children.
79 Gullstrand C et al. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study.
80 Gylling H, Miettinen TA. Totta ja tarua ravinnon kasvisteroleista ja kasvistanoleista.
81 Gylling H, Miettinen TA. Kolesterolin endogeeninen tuotanto ja saanti ravinnosta.
82 Haatainen K et al. Magneettisairaalan idea sovellettuna Suomeen.
83 Halinen M et al. Diagnoosien kirjaamiskäytännöissä kehittämisen varaa.
84 Halinen M et al. Laskimotukoksen ehkäisy lonkan ja polven elektiivisen tekonivelleikkauksen yhteydessä.
85 Hallikainen M et al. Effect of parenteral serum plant sterols on liver enzymes and cholesterol metabolism in a patient with short bowel syndrome.
86 Hallikainen M et al. Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes.
87 Hammerstedt A et al. High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects.
88 Hannula M et al. Comparison between artificial neural network and multilinear regression models in an evaluation of cognitive workload in a flight simulator.
89 Hansson Petersen CA et al. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.
90 Harju T et al. Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity.
91 Harvima IT. Induction of matrix metalloproteinase-9 in keratinocytes by histamine.
92 Harvima IT et al. Is there a role for mast cells in psoriasis?
93 Hassinen M et al. Cardiorespiratory fitness as a feature of metabolic syndrome in older men and women.
94 Haukilahti R-L et al. Lääkäri 2003 -tutkimus. Muuttuuko lääkärin työ - ja mihin suuntaan?
95 Haukilahti R-L et al. Miten lääkärit ovat kokeneet työtahdin muuttuneen työssäoloaikanaan?
96 He H-G et al. Increasing nurses' knowledge and behavior changes in nonpharmacological pain management for children in China.
97 Heckman CA et al. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
98 Heikkilä J, Hynynen K. Simulations of lesion detection using a combined phased array LHMI-technique.
99 Heikkinen M, Saarela A. Onko endoskopiatoiminta Suomessa riittävän tasokasta?
100 Heinonen MV et al. Functions of orexins in peripheral tissues.
101 Heinonen S, Geirsson RT. You are what you eat and what you practice.
102 Heiskanen N et al. Placenta percreta: Methotrexate treatment and MRI findings.
103 Heiskanen N et al. Blood pressure and heart rate variability analysis of orthostatic challenge in normal human pregnancies.
104 Heiskanen-Kosma T et al. Simkania negevensis may be a true cause of community acquired pneumonia in children.
105 Helgadottir A et al. The same sequence variant 9p21 associates with myocardial infarction abdominal aortic aneurysm and intracranial aneurysm.
106 Helin M et al. Phospholipases A2 in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma.
107 Helisalmi S et al. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
108 Helisalmi S et al. Genetic study between SIRT1, PPARD, PGC-1alfa genes and Alzheimer's disease.
109 Helminen HJ et al. Nivelrikon ehkäisy on mahdollista.
110 Helske S et al. Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves.
111 Hernesniemi J et al. Microneurosurgical management of anterior communicating artery aneurysms.
112 Hernesniemi J et al. Microsurgical treatment of third ventricular colloid cysts by interhemispheric far lateral transcallosal approach - experience of 134 patients.
113 Herukka S-K et al. CSF Abeeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy.
114 Hirvonen K et al. Välinehuolto.
115 Holi MM et al. Detecting suicidality among adolescent outpatients: evaluation of trained clinicians' suicidality assessment against a structured diagnostic assessment made by trained raters.
116 Holmberg L et al. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
117 Horwich A et al. Prostate cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
118 Huddart R et al. Testicular seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
119 Huddart R et al. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
120 Huhtala A et al. In vitro biocompatibility of degradable biopolymers in cell line cultures from various ocular tissues: extraction studies.
121 Huhtiniemi T et al. Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.
122 Huotari A, Herzig KH. Vitamin D and living in northern latitudes - an endemic risk area for vitamin D deficiency.
123 Hurttila H et al. Oxidative stress-inducible lentiviral vectors for gene therapy.
124 Huusko J et al. Generation of transgenic and knockdown mice with lentiviral vectors and RNAi techniques.
125 Hynynen E et al. Cardiac autonomic responses to standing up and cognitive task in overtrained athletes.
126 Hyppölä H et al. Sattumaa vai harkintaa - lääkärien erikoisalavalintaan vaikuttavat tekijät.
127 Hyvärinen A et al. Cutaneous Electrical Stimulation treatment in unresolved facial nerve paralysis: an exploratory study.
128 Häkkinen MR et al. Quantitative determination of underivatized polyamines by using isotope dilution RP-LC-ESI-MS/MS.
129 Hämäläinen A et al. Apolipoprotein E epsilon4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.
130 Hämäläinen S et al. Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: causes and consequences.
131 Höfling I et al. Preliminary experience of a single session of low-energy extracorporeal shock wave treatment for chronic plantar fasciitis.
132 Ilanne-Parikka P et al. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish diabetes prevention study.
133 Immonen A et al. Kuka hyötyy epilepsiakirurgiasta?
134 Immonen RJ et al. Manganese enhanced MRI detects mossy fiber sprouting rather than neurodegeneration, gliosis or seizure-activity in the epileptic rat hippocampus.
135 Isojoki I et al. Priority criteria tool for elective specialist level adolescent psychiatric care predicts treatment received.
136 Jaaskelainen E et al. Polymorphism of the interleukin 1 receptor antatgonist (IL1Ra) gene and placental abruption.
137 Jantunen E. Myelooman muuttuva hoito.
138 Jantunen E. Aikuispotilaiden autologiset kantasolusiirrot.
139 Jantunen E et al. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
140 Jantunen E et al. Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.
141 Jantunen E, Kuittinen T. Blood stem cell mobilization and collection in patients with lymphoproliferative diseases: practical issues.
142 Jantunen E et al. Iäkkäiden potilaiden pahanlaatuisten veritautien hoito.
143 Jantunen E et al. Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients.
144 Jartti T, Remes S. Lasten allergisten sairauksien esiintyvyys ja luonnollinen kulku.
145 Jartti T, Remes S. Eläinallergia.
146 Jauhiainen AM et al. Differential hypometabolism patterns according to mild cognitive impairment subtypes.
147 Jin H-T et al. A polyamine analog bismethylspermine ameliorates severe pancreatitis induced by intraductal infusion of taurodeoxycholate.
148 Jin HT et al. Polyamine levels in the pancreas and the blood change according to the severity of pancreatitis.
149 Jokela TA et al. Mannose inhibits hyaluronan synthesis by down-regulation of the cellular pool of UDP-N-acetylhexosamines.
150 Jokela TA et al. Induction of hyaluronan cables and monocyte adherence in epidermal keratinocytes.
151 Jokinen JJ et al. Prospective assessment of quality of life of octogenarians after cardiac surgery: factors predicting long-term outcome.
152 Joukainen A. New Bioabsorbable Implants for the Fixation of Metaphyseal Bone. An Experimental and Clinical Study.
153 Juhakoski R et al. Factors affecting self-reported pain and physical function in patients with hip osteoarthritis.
154 Jukarainen NM et al. Quantification of 1H NMR spectra of human cerebrospinal fluid: a protocol based on constrained total-line-shape analysis.
155 Julkunen P et al. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study.
156 Julkunen P. Relationships between Structure, Composition and Function of Articular Cartilage.
157 Julkunen P et al. Uncertainties in indentation testing of articular cartilage: a fibril-reinforced poroviscoelastic study.
158 Julkunen P et al. Mechanical characterization of articular cartilage by combining magnetic resonance imaging and finite-element analysis - a potential functional imaging technique.
159 Julkunen P et al. Efficient reduction of stimulus artefact in TMS-EEG by epithelial short-circuiting by mini-punctures.
160 Julkunen P et al. Stress-relaxation of human patellar articular cartilage in unconfined compression: prediction of mechanical response by tissue composition and structure.
161 Juonala M et al. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: The Cardiovascular Risk in Young Finns Stydy.
162 Juonala M et al. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood. The cardiovascular risk in young Finns study.
163 Jurvelin JS et al. Fysikaaliset ja kemialliset menetelmät nivelrikon varhaisessa osoittamisessa.
164 Juutilainen A et al. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.
165 Jylhä V, Kinnunen U-M. Terveydenhuollon sähköiset tietokannat - tiedon hyödyntäminen tutkimustyössä ja johtamisessa.
166 Jylhä V et al. The use of structured documentation in electronic patient records: Case diabectics.
167 Jyrkkänen H-K et al. Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo.
168 Järvelä K et al. Levosimendan in aortic valve surgery: cardiac performance and recovery.
169 Järvelä S et al. Decreased expression of antioxidant enzymes is associated with aggressive features in ependymomas.
170 Järvelä S et al. Carbonic anhydrase IX in oligodendroglial brain tumors.
171 Järvinen K et al. Nanoteknologia lääkehoidon työkaluna.
172 Jääskeläinen E et al. CTLA-4 polymorphism 49A-G is associated with placental abruption and preeclampsia in Finnish women.
173 Jääskeläinen J et al. Androgen receptor gene CAG repeat length in women with metabolic syndrome.
174 Kaarniranta K, Sorri I. Diabeteksen aiheuttamat silmämuutokset.
175 Kaartinen K et al. Inflammatory markers and the progression of IgA glomerulonephritis.
176 Kaikkonen MU et al. Targeting and purification of metabolically biotinylated baculovirus.
177 Kaipiainen-Seppänen O et al. Two pathogenic CIAS1 mutations and plasma cytokine profile in a Finnish patient with familial cold autoinflammatory syndrome responsive to anakinra.
178 Kaleva E et al. In-vitro comparison of time-domain, frequency-domain and wavelet ultrasound parameters in diagnostics of cartilage degeneration.
179 Kallio P et al. Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individulas with the metabolic syndrome1-3.
180 Kalliokoski M-L. Psykoosipotilaan hoitosuhde.
181 Kankaanranta T et al. Kunnalliselle vai yksityiselle? Pelkästään taloudelliset tekijät eivät ohjaa lääkärien työpaikan valintaa.
182 Kankkunen P, Vehviläinen-Julkunen K. Potilaiden sosiodemografisten muuttujien yhteydet riippuviin muuttujiin.
183 Kankkunen PM et al. A tale of two countries: comparison of the perceptions of analgesics among finnish and american parents.
184 Kanninen K et al. Nuclear factor erythroid 2-related factor 2 protects against beta amyloid.
185 Kaptoge S et al. Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on male osteoporosis (NEMO) study.
186 Karamanakos PN. Furazolidone and serotonin syndrome: is there any association?
187 Karamanakos PN. The possibility of serotonin syndrome brought about by the use of metronidazole.
188 Karamanakos PN. Intoxication with over-the-counter antitussive medication containing dihydrocodeine and chlorpheniramine causes generalized convulsion and mixed acidosis.
189 Karamanakos PN, Panteli ES. Comment on "Dextromethorphan-induced serotonin syndrome".
190 Karamanakos PN et al. Disulfiram neuropathy: two cases of distal axonopathy.
191 Karamanakos PN et al. Comment on "Disulfiram-like effect of cyproterone acetate" [Z. Nitzan, M. Dan, Eur. J. Obstet. Gynecol. Reprod. Biol. (2007)].
192 Karamanakos PN et al. Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicity.
193 Karavirta L et al. Estimation of maximal heart rate using the relationship between heart rate variability and exercise intensity in 40-67 years old men.
194 Karhunen L, Herzig K-H. Neuroendocrinological regulation of food intake.
195 Karhunen LJ et al. Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans.
196 Karinen H. Genetics and Family Aspects of Coeliac Disease.
197 Karjalainen J et al. Recent developments and future prospects in bone ultrasound diagnostics.
198 Karjalainen J et al. Ultrasonic assessment of cortical bone thickness In Vitro and In Vivo.
199 Karjalainen J et al. Dual-frequency ultrasound technique minimizes errors induced by soft tissue in ultrasound bone densitometry.
200 Karlsson L et al. One-year course and predictors of outcame of adolescent depression: a case-control study in Finland.
201 Karlsson S et al. HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis.
202 Karlsson S et al. Vascular endothelial growth factor in severe sepsis and septic shock.
203 Karpanen T et al. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
204 Karppinen J et al. Iskiaskivun hoito.
205 Karstila K et al. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
206 Karvonen K et al. Suicide after hospitalization in the eldery: a population based study of suicides in Northern Finland between 1988-2003.
207 Kataja V et al. Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
208 Kauppi A et al. Maternal depression and filicide - case stydy of ten mothers.
209 Kaurijoki S et al. Association of serotonin transporter promoter regulatory region polymorphism and cerebral activity to visual presentation of food.
210 Kemppainen T et al. Effect of weight reduction on rhinometric measurements in overweight patiens with obstructive sleep apnea.
211 Kemppainen T et al. Repeated early debridement does not provide significant symptomatic benefit after ESS.
212 Kemppainen TA et al. Unkilned and large amounts of oats in the coeliac disease diet: a randomized, controlled study.
213 Kemppinen K. Äidin herkkyys vauvan viesteille - arviointi, jatkuvuus ja riskit.
214 Keski-Nisula L. Raskausajan diabetes yleistyy: liikaa energiaa, liian vähän liikuntaa ja insuliinia.
215 Ketola A et al. Oncolytic semliki forest virus vector as a novel candidate against unresectable osteosarcoma.
216 Ketonen M et al. Long-term prognosis after coronary artery bypass surgery.
217 Kilpeläinen TO et al. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome. The Finnish Diabetes Prevention Study.
218 Kilpeläinen TO et al. SNPs in PPARG associte with type 2 diabetes and intract with physival activity.
219 Kinnunen U-M et al. Haavan dokumentointiin kehitettyjen arviointikriteerien toteutuminen haavanhoidon kirjauksissa.
220 Kinnunen U-M et al. Haavanhoidon sähköisen kirjaamisen kehittäminen.
221 Kirjavainen A et al. Prox1 interacts with Atoh1 and Gfi1, and regulates cellular differentiation in the inner ear sensory epithelia.
222 Kivelä AM et al. Enterolactone induces heme oxygenase-1 expression through nuclear factor-E2-related factor 2 activation in endothelial cells.
223 Kivipelto M et al. Apolipoprotein E epsilon4 magnifiles lifestyle risks for dementia: a population-based study.
224 Kiviranta P et al. Indentation diagnostics of cartilage degeneration.
225 Kiviranta PH et al. Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone.
226 Klomek AB et al. Childhood bullying as a risk for later depression and suicidal ideation among Finnish males.
227 Koikkalainen J et al. Dynamic probabilistic atlas of functional brain regions for transcranial magnetic stimulation.
228 Koikkalainen JR et al. Early familial dilated cardiomyopathy: Identification with determination of disease state parameter from cine MR image data.
229 Koivisto T et al. Aivovaltimoaneurysman hoito - onko koolla väliä?
230 Koivisto T et al. Aivovaltimoaneurysmat - kuka hoitaa, miten ja missä?
231 Koivu A et al. Työnohjauksen tarve yliopistosairaalan somaattisilla erikoisaloilla. Työnohjaus voi ehkäistä uhkaavan työuupumuksen.
232 Koivula M-K et al. Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series.
233 Koivumaa-Honkanen H et al. Mental health and well-being in a 6-year follow-up of patients with depression. Assesments of patients and clinicians.
234 Koivunen J et al. PET amyloid ligand (11C)PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment.
235 Kojo K et al. Reliability and validity of bioimpedance measurement device in the assessment of UVR damage to the skin.
236 Kokki H et al. Diclofenac readily penetrates the cerebrospinal fluid in children.
237 Kolehmainen M et al. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study.
238 Komulainen P et al. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.
239 Kondrashova A et al. Lower economic status and inferior hygienic environment may protect against celiac disease.
240 Kondrashova A et al. Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments.
241 Koponen H. Skitsofreniapotilaan oireiden seuranta ja lääkehoito.
242 Koponen H. Somatisk uppföljning och läkemedelsbehandling av schizofrenipatienter.
243 Koponen H. Somatic follow-up and drug treatment in schizophrenia patients.
244 Koponen H. Sydänperäiset äkkikuolemat ja psyykenlääkkeet.
245 Koponen H. Psykoosit ja kognitiivinen prosessointi.
246 Koponen H et al. Schizophrenia and sudden cardiac death - a review.
247 Koponen H et al. Metabolic syndrome predisposes to depressive symptoms: A population-based 7-year follow-up study.
248 Koponen H, Leinonen E. Iäkkään masennus: tunnistaminen ja hoito.
249 Koponen H et al. Insulin resistance and lipid levels in adolescents with familial risk for psychosis.
250 Koponen H et al. No difference in insulin resistance and lipid levels between controls and adolescense subjects who later develop psychosis.
251 Korhonen RK et al. Importance of collagen orientation and depth-dependent fixed charge densities of cartilage on mechanical behavior of chondrocytes.
252 Korhonen T et al. Tupakointi ja masennus.
253 Korhonen T et al. Implementing child-focused family nursing into routine adult psychiatric practice: hindering factors evaluated by nurses.
254 Korhonen T et al. Do nurses working in adult psychiatry take into consideration the support network of families affected by parental mental disorder?
255 Korpisalo P et al. Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic ...
256 Korpisalo P et al. Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs.
257 Korppi M et al. Early exposure and sensitization to cat and dog: Different effects on asthma risk after wheezing in infancy.
258 Korppi M et al. Asthma after early RSV infection - How to control?
259 Korvenoja P et al. Veno-venous extracorporeal membrane oxygenation in surgery for bronchial repair.
260 Koskela AK et al. Serotonin transporter binding and acquired obesity - An imaging study of monozygotic twin pairs.
261 Koskela HO et al. Hypertonic saline cough provocation test with salbumatol pre-treatment: evidence for sensorineural dysfunction in asthma.
262 Koskela HO et al. Simultaneous versus video counting of coughs in hypertonic cough challenges.
263 Koskela RM et al. Human leucocyte antigen and TNF(alfa) polymorphism association in microscopic colitis.
264 Koskela T-H. Terveyspalveluiden pitkäaikaisen suurkäyttäjän ennustekijät. The Prognostic Risk Factors for Long-Term Frequent Use of the Primary Health Care Services.
265 Koskenvuo M et al. Respiratory viral infections in children with leukemia.
266 Koskinen J et al. How to use bibliometric methods in evaluation of scientific research? An example from Finnish schizophrenia research.
267 Koukkunen H et al. Coronary events in persons aged 75 years or older in Finland from 1995 to 2002. The FINAMI study.
268 Kovacs GG et al. Mixed brain pathologies in dementia: the BrainNet Europe consortium experience.
269 Kozakova M et al. Body composition and common carotid artery remodeling in a healthy population.
270 Kröger H et al. Murtumat. Osteoporoosi. Kuntoutus.
271 Kumpulainen E et al. How readily does ketorolac penetrate cerebrospinal fluid in children?
272 Kumpulainen EJ et al. Long-term outcome of adjuvant chemotherapy cyclophosphamide, mitoxantone, and fluorouracil in women with breast cancer.
273 Kumpulainen K. Psychiatric conditions associated with bullying.
274 Kurkijärvi JE et al. The zonal architecture of human articular cartilage described by T2 relaxation time in the presence of Gd-DTPA2-.
275 Kuulasmaa T et al. WNT-4 mRNA expression in human adrenocortical tumors and cultured adrenal cells.
276 Kuusisto E et al. Use of p62/SQSTM1 antibodies for neuropathological diagnosis.
277 Kvist T, Vehviläinen-Julkunen K. Ihmisläheinen hoito -mittarin kehittäminen ja innovatiivinen käyttö.
278 Kyrgiannis K et al. Optimal treatment of a recurrent giant craniopharyngioma: lessons from a case.
279 Kälviäinen R et al. Clinical picture of EPM1-Unverricht-Lundborg disease.
280 Kärkkäinen M et al. Association between functional capacity tests and fractures: an eight-year prospective population-based cohort study .
281 Laakkonen JP et al. Baculovirus-mediated immediate-early gene expression and nuclear reorganization in human cells.
282 Laakso M. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
283 Laakso M et al. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.
284 Laaksonen DE et al. Long-term repeatability of measures of early insulin secretion derived from an intravenous glucose tolerance test and conversion from impaired glucose tolerance to diabetes.
285 Laaksonen DE et al. Dyslipidaemia as a predictor of hypertension in middle-aged men.
286 Laasanen J et al. Gamma 2 actin gene (enteric type) polymorphism is not associated with obstetric cholestasis or preeclampsia.
287 Lahtinen P et al. Remifentanil infusion does not induce opioid tolerance after cardiac surgery.
288 Laitinen T et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects.
289 Lakkisto P et al. The heme oxygenase inducer hemin protects against cardiac dysfunction and ventricular fibrillation in ischaemic/reperfused rat hearts: role of connexin 43.
290 Lammentausta E et al. T2, Carr-Purcell T2 and T1rho of fat and water as surrogate markers of trabecular bone structure.
291 Lammi MJ et al. Nivelrikon välittäjäaineet.
292 Lampinen R et al. Yli 40-vuotiaiden odottavien äitien arviointeja äitiyshuollon palveluista.
293 Lane R et al. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
294 Lanki T et al. Hourly variation in fine particle exposure is associated with transiently increased risk of ST segment depression.
295 Lappalainen S et al. Androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation in children with premature adrenarche.
296 Lappalainen S et al. ACTH receptor promoter polymorphism associates with severity of premature adrenarche and modulates hypothalamo-pituitary-adrenal axis in children.
297 Lappalainen T et al. Serum concentrations and expressions of serum amyloid A and leptin in adipose tissue re interrelated: the Genobin study.
298 Laukkanen E. Otan mitä sinulla on ja lähden - nuoren hoitosuhteesta.
299 Laurema A et al. The administration of an adenoviral thymidine kinase suicide gene to the uterine artery of rabbits does not affect fertility: a safety study of pregnant and nonpregnant rabbits and their offspring.
300 Lee JC et al. WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels.
301 Lehecka M et al. Microneurosurgical management of aneurysms at A3 segment of anterior cerebral artery.
302 Lehecka M et al. Microneurosurgical management of aneurysms at A4 and A5 segments and distal cortical branches of anterior cerebral artery.
303 Lehecka M et al. Microneurosurgical management of aneurysms at the A2 segment of anterior cerebral artery (proximal pericallosal artery) and its frontobasal branches.
304 Lehecka M et al. Distal anterior cerebral artery aneurysms: treatment and outcome analysis of 501 patients.
305 Lehto S et al. Temporal cortex dopamine D2/3 receptor binding in major depression.
306 Lehto S, Tolmunen T. Onko tietoisuustaitojen harjoittelulla terveysvaikutuksia?
307 Lehto SM et al. Metabolic syndrome - the impact of depression .
308 Lehto SM et al. Low HDL cholesterol associates with major depression in a sample with a 7-year history depressive symptoms.
309 Lehto SM et al. Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy .
310 Lehto SM et al. Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study.
311 Lehtonen J-M et al. Speed and quality in Coronary Artery Bypass Graft (CABG) surgery: is there a connection?
312 Lehtonen ST et al. Does the oxidative stress in chronic obstructive pulmonary disease cause thioredoxin/peroxiredoxin oxidation?
313 Leinonen E, Koponen H. Iäkkään masennuksen tunnistaminen ja hoito.
314 Leinonen T et al. Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumor recurrence and unfavourable outcome in non-small cell lung cancer.
315 Leinonen V et al. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11- labeled Pittsburgh compound B.
316 Lepola U, Koponen H. Laadukas remissio on masennuksen lääkehoidon haaste.
317 Leppikangas H et al. Effects of levosimendan on indocyanine green plasma disappearance rate and the gastric mucosal-arterial pCO2 gradient in abdominal aortic aneurysm surgery.
318 Leppä S et al. Diffuusin suurisoluisen B-solulymfooman hoito.
319 Lesch HP et al. Generation of lentivirus vectors using recombinant baculoviruses.
320 Levonen A-L et al. Antioxidant gene therapy for cardiovascular disease: current status and future perspectives.
321 LI LP et al. Fluid pressure driven fibril reinforcement in creep and relaxation tests of articular cartilage.
322 Liikavainio T et al. Physical function and properties of quadriceps femoris muscle in men with knee osteoarthritis.
323 Liimatainen TJ et al. 1H MR spectroscopic imaging of phospholipase-mediated membrane lipid release in apoptotic rat glioma in vivo.
324 Lindi V et al. The G-250A polymorphism in the hepatic lipase gene promotor is associated with changes in hepatic lipase activity and LDL cholesterol:The KANWU study.
325 Lindström J et al. Determinants for the effectiveness of lifestyle intervention in the Finnish diabetes prevention study.
326 Lindström J, Uusitupa M. Lifestyle intervention, diabetes, and cardiovascular disease.
327 Lintula H et al. Laparoscopic versus open orchidopexy in children with intra-abdominal testes.
328 Lisowska A et al. Chronic pouchitis is not related to small intestine bacterial overgrowth.
329 Liu R et al. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.
330 Liu X-Q et al. IL5RA and TNFRSF6B gene variants are associated with sporadic IgA nephropathy.
331 Lundberg A et al. Lipopolysaccharide-induced immune responses in relation to the TLR4(Asp299Gly) gene polymorphism.
332 Luomajoki H et al. Movement control tests of the low back; evaluation of the difference between patients with low back pain and healthy controls.
333 Luopajärvi K et al. Enhanced levels of cow´s milk antibodies in infancy in children who develop type 1 diabetes later in childhood.
334 Lupsakko T, Ikäheimo K. Iäkkäiden aistiongelmat: kun ei kuule ja näkökin reistaa.
335 Lämsä R et al. Genetic study evaluating LDLR polymorphisms and Alzheimer's disease.
336 Löppönen. Dental arch morphology in children with sleep-disordered breathing.
337 Löppönen H. Nuorten kuulonsuojeluun on syytä kiinnittää huomiota.
338 Löppönen HJ, Välimaa T. Comparison of the body-worn CSI-PRO+ and the behind-the-ear-worn TEMPO+ cochlear implant system in Finnish-speaking adult CI users: any differences in results with experienced listeners?
339 Löyttynen A-M et al. Introducing interpersonal psychotherapy (IPT) to psychiatric outpatient care: early experiences in training therapists and treating depressed outpatients.
340 Maaranen P. Dissociation in the Finnish General Population.
341 Maaranen P et al. The course of dissociation in the general population: a 3-year follow-up study.
342 Machová E et al. Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice.
343 Mager U et al. Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
344 Mager U et al. Expression of ghrelin gene in peripheral blood mononuclear cells and plasma ghrelin concentrations in patients with metabolic syndrome.
345 Magga J et al. Significance of plasma levels of N-Terminal pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
346 Mahindu A et al. Similarities and differences in aneurysmal subarachnoid haemorrhage between eastern Finland and northern Sydney.
347 Makkonen I et al. Serotonin and dopamine transporter binding in children with autism determined by SPECT.
348 Malm TM et al. Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of alzheimer´s disease.
349 Manninen H. Femoropopliteal occlusive disease (indications for treatment, technical aspects, current results, and troubleshooting complications).
350 Manninen H. Tarvitaanko enää katetriangiografiaa ?
351 Manninen H et al. Endangered cerebral blood supply after closure of left subclavian artery: postmortem and clinical imaging studies.
352 Manninen HI et al. Stent-assisted coil embolization of wide-necked renal artery bifurcation aneurysms.
353 Manninen HI et al. Endovascular salvage on nonmaturing autogenous hemodialysis fistulas: Comparison with endovascular therapy of failing mature fistulas.
354 Marttila J et al. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple [beta]-cell autoantibodies.
355 Mattsson N et al. Arterial structure and function in young adults with the metabolic symdrome: the Cardiovascular Risk in Young Finns Study.
356 Meigal AI et al. Novel parameters of surface EMG in patients with Parkinson's disease and healthy young and old controls.
357 Meriläinen S et al. Acute edematous and necrotic pancreatitis in a porcine model.
358 Miettinen KH et al. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy.
359 Miettinen KH et al. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy.
360 Miettinen KH et al. Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure.
361 Miettinen TA, Gylling H. Vascular effects of diets, especially plant sterol ester consumption.
362 Miettinen TA et al. Adolescent cholesterol metabolism predicts coronary risk factors at middle age: the cardiovascular risk in young Finns study.
363 Miettinen TA et al. Synthesis and absorption of cholesterol in Finnish boys by serum non-cholesterol sterols. The cardiovasvular risk in young Finns study.
364 Miettola J et al. Metabolic syndrome is accociated with self-perceived depression.
365 Miettola J et al. Metabolic syndrome is associated with impaired health-related quality of life: Lapinlahti 2005 study.
366 Mikhaylova IV et al. Leukemia inhibitory factor as a regulator of steroidogenesis in human NCI-H295R adrenocortical cells.
367 Minkeviciene R et al. Cognition-enhancing and anxiolytic effects of memantine.
368 Minkeviciene R et al. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
369 Mononen T et al. Rearrangements in the flanking sequences of the triplet repeat of the FMR1 gene give clues to the mechanisms involved in repeat instability in fragile X.
370 Multimäki P et al. Childhood predictors of military fitness: a prospective, community-based, follow-up study from age 8 to age 18.
371 Mustonen E et al. Thrombospondin-4 expression is rapidly upregulated by carciac overload.
372 Mustonen T et al. Heterogeneity of cerebral perfusion one week after haemorrhage is an independet predictor of clinical outcome in patients with aneyrysmal subarachnoid haemorrhage.
373 Myllymaa S et al. Development of flexible microelectrode arrays for recording cortical surface field potentials.
374 Mäkeläinen P et al. A survey of rheumatoid arthritis patients self-efficacy.
375 Mäkinen A et al. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
376 Mäkinen J et al. Negative symptoms in schizofrenia - a review.
377 Mäkinen S et al. Coaccumulation of calcium and b-amyloid in the thalamus after transient middle cerebral artery occlusion in rats.
378 Mäkinen V-P et al. Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes.
379 Mäntyselkä P. Balancing act with geriatric pain treatment.
380 Mäntyselkä P et al. Chronic pain, impaired glucose tolerance and diabetes: A commynity-based study.
381 Mäntyselkä P et al. Glucose regulation and chronic pain at multiple sites.
382 Mättö M et al. Human B cells and macrophages cooperate in T-cell-independent type 2 response.
383 Määttä A-M et al. Replication competent Semliki Forest virus prolongs survival in experimental lung cancer.
384 Nevala T et al. Outcome of symptomatic, unruptured abdominal aortic aneurysms after endovascular repair with the Zenith stent-graft system .
385 Niemelä S et al. What predicts illicit drug use versus police-registered drug offending? . Findings from the Finnish "From a boy to a man" birth cohort study.
386 Nieminen J et al. Disturbed synthesis of type II collagen interferes with rate of bone formation and growth and increases bone resorption in transgenic mice.
387 Nieminen P et al. Indications of hepatic and cardiac toxicity caused by subchronic Tricholoma flavovirens consumption.
388 Niinimäki RA et al. Osteonecrosis in children treated for lymphoma or solid tumors.
389 Niinisalo P et al. Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the health 2000 study.
390 Nikkilä K et al. Serum sterols in patients with primary biliary cirrhosis and acute liver failure before and after liver transplantation.
391 Nikolajev K et al. Birth weight and adult lung function: a within-pair analysis of twins followed up from birth.
392 Nissi M. Magnetic Resonance Parameters in Quantitative Evaluation of Articular Cartilage. Studies on T(1) and T(2) Relaxation Time.
393 Nissinen MJ et al. Responses of surrogate markers of cholesterol absorption and synthesis to changes in cholesterol metabolism during various amounts of fat and cholesterol feeding among healthy men.
394 Nissinen MJ et al. Effects of dietary cholesterol and fat on serum non-cholesterol sterols according to different apolipoprotein E subgroups among healthy men.
395 Noè F et al. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy.
396 Nuutinen U et al. PDTC enables type I TRAIL signaling in type II follicular lymphoma cells.
397 Nykänen I. Sepelvaltimotaudin prevention kehitys Suomessa vuosina 1996-2005. Development the Prevention of Coronary Heart Diseases in Finland 1996-2005.
398 Nyman H et al. Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma.
399 Nyyssönen T et al. The increasing incidence and difference in sex distribution of Achilles tendon rupture in Finland in 1987-1999.
400 Näntö-Salonen K et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.
401 O'Dushlaine CT et al. An assessment of the Irish population for large-scale genetic mapping studies involving epilepsy an other complex diseases.
402 Odermarsky M et al. Respiratory infection recurrence and passive smoking in early atherosclerosis in children and adolescents with type 1 diabetes.
403 Oikari S et al. Downregulation of PPARs and SREBP by acyl-CoA-binding protein overexpression in transgenic rats.
404 Oikari S et al. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
405 Oikarinen M et al. Analysis of pancreas tissue in a child positive for islet cell antibodies.
406 Ojala JO et al. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells.
407 Ojala K et al. Characterization of metabolic syndrome among forensic psychiatric inpatients.
408 Ojala K et al. Statins are effective in treating dyslipidemia among psychiatric patiens using second-generation antipsychotic agents.
409 Olkku A, Mahonen A. Wnt and steroid pathways control glutamate signalling by regulating glutamine synthetase activity in osteoblastic cells.
410 Oravisjärvi K et al. Air pollution and PEF measurements of children in the vicinity of a steel works.
411 Ortiz F et al. Is Cystatin C more sensitive than creatinine in detecting early chronic allograft nephropathy?
412 Palonen R et al. Lääkevalmisteiden tavallisimmat haittavaikutukset Suomessa.
413 Parkkinen L et al. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance.
414 Partanen P et al. Magneettisairaalamalli erinomaisen hoitotyön mahdollistajana.
415 Pasanen MK et al. Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate.
416 Pasonen-Seppänen SM et al. All-trans retinoic acid-induced hyaluronan production and hyperplasia are partly mediated by EGFR signaling in epidermal keratinocytes.
417 Patel S et al. Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects.
418 Pelkonen A, Piippo-Savolainen E. Tupakka ja astma.
419 Pelkonen M. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality.
420 Pelkonen M et al. Adolescent risk factors for episodic and persistent depression in adulthood. A 16-year prospective follow-up study of adolescents.
421 Pennanen H et al. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
422 Peura P et al. Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men.
423 Peurala SH et al. Restoration of normal cortical excitability and gait ability in acute stroke after intensive rehabilitation.
424 Pietilä A-M et al. Terveyden edistämisen tutkimuksen eettinen ja menetelmällinen perusta.
425 Pihlaja R et al. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
426 Piippo-Savolainen E, Korppi M. Wheezy babies - wheezy adults? Review on long-term outcome until adulthood after early childhood wheezing.
427 Pikkarainen M et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry.
428 Pilvi TK et al. Metabolomic changes in fatty liver can be modified by dietary protein and calcium during energy restriction.
429 Pirttilä T. Lievä kognitiivinen heikentyminen -ennusteeltaan heterogeeninen oireyhtymä.
430 Pitkäaho T et al. Hoitohenkilöstön mitoituksen tunnusluvut. Tunnuslukujen saatavuus tietojärjestelmistä ja niiden käytettävyys. Pilottitutkimus Kuopion yliopistollisen sairaalan sisätautien klinikassa.
431 Posio J et al. Pitkäänkin sairastaneet skitsofreniapotilaat hyötyvät ryhmäkuntoutuksesta.
432 Pulkkinen K et al. Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210.
433 Purhonen AK et al. Duodenal phytohaemagglutinin (red kidney bean lectin) stimulates gallbladder contraction in humans.
434 Purhonen AK et al. TRPA1 channel activation induces cholecystokinin release via extracellular calcium.
435 Purhonen M et al. The impact of stimulus type and early motherhood on attentional processing.
436 Purhonen S et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.
437 Purmonen T et al. Economic evaluation of sunitinib malate in second-line treatment of metastatic renal cell carcinoma in Finland.
438 Purokivi M et al. Utility of cough response during hypertonic histamine challenge in diagnosing asthma.
439 Purokivi M et al. Äkillinen hengitysvajaus - metadonikorvaushoidon aloittamiseen liittyvä harvinainen haittavaikutus.
440 Pylkkänen K, Lehtonen J. Terveydenhuoltolaki ja mielenterveyspalvelut.
441 Pääkkönen M. Laihdutusleikkaukset KYS:ssa.
442 Pölkki T et al. Imagery-induced relaxation in children's postoperative pain relief: a randomized pilot study.
443 Qvarnstrom M et al. Salivary lysozyme and prevalent hypertension.
444 Raij T et al. Parallel input makes the brain run faster.
445 Raitakari OT et al. Plant stanol ester consumption and arterial elasticity and endothelial function.
446 Raitanen MP. The role of BTA stat test in follow-up of patients with bladder cancer: results from FinnBladder studies.
447 Ranta-aho PO et al. Estimation of single-trial fMRI BOLD responses using combined EEG and fMRI measurements.
448 Rautsi O et al. Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
449 Remes ST et al. High birth weight, asthma and atopy at the age of 16 yr.
450 Remes V et al. Polven nivelrikon kirurginen hoito.
451 Riekkinen O. Development and Application of Ultrasound Backscatter Methods for the Diagnostics of Trabecular Bone.
452 Riekkinen O et al. Dual-frequency ultrasound - new pulse-echo technique for bone densitometry.
453 Rieppo J et al. Practical considerations in the use of polarized light microscopy in the analysis of the collagen network in articular cartilage.
454 Riikonen R. Insulin-like growth factors. Neurobiological regulators of brain growth in autism?
455 Rilla K et al. Pericellular hyaluronan coat visualized in live cells with a fluorescent probe is scaffolded by plasma membrane protrusions.
456 Rinne K et al. A randomized trial comparing TVT with TVT-O: 12-months results.
457 Rissanen M-L et al. Descriptions of self-mutilation among Finnish adolescents: A qualitative descriptive inquiry.
458 Rissanen M-L et al. Viiltojen viestit - itsensä viiltäminen nuorten kuvaamana.
459 Rissanen M-L et al. Parental conceptions of self-mutilation among Finnish adolescents.
460 Rissanen SM et al. Surface EMG and acceleration signals in Parkinson`s disease: feature extraction and cluster analysis.
461 Rissanen SM et al. Analysis of dynamic EMG and acceleration measurements in Parkinson`s disease.
462 Rissanen TT et al. High-resolution ultrasound perfusion imaging of therapeutic angiogenesis.
463 Ritakallio M et al. Continuity, comorbidity and longitudinal associations between depression and antisocial behaviour in middle adolescence: a 2-year prospective follow-up study.
464 Ruotsalainen E et al. Markes of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects.
465 Ryhänen T et al. Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells.
466 Rytilä P et al. Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function.
467 Ryynänen O-P et al. Predicting treatment effectiveness in spinal pain - application of a bayesian predicting model.
468 Räisänen S et al. Lateraalisen episiotomian käyttö synnytyksen hoidossa.
469 Räty JK et al. Improving safety of gene therapy.
470 Rönkkö S et al. Histopathology of the three implanted degradable biopolymers in rabbit eye.
471 Saarelainen H et al. Subtle changes in ADMA and l-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation.
472 Saarelainen S et al. Animal-derived lipocalin allergens exhibit immunoglobulin E cross-reactivity.
473 Saarelainen SA et al. Immunotherapeutic potential of the immunodominant T-cell epitope of lipocalin allergen Bos d 2 and its analogues.
474 Saarinen P. Maisema ja mielenterveys. Ajatuksia Kalle Päätälon romaanien mekityksestä mielenterveysongelmien ehkäisyssä.
475 Saarinen P. Näkökohtia vakavassa itsemurhavaarassa olevan potilaan hoitosuhteesta.
476 Saavalainen PM et al. School performance of adolescents born preterm: neuropsychological and background correlates.
477 Saharinen T et al. Health-related quality of life in a population-based sample of men with long-term mental symptoms.
478 Sakr Y et al. Sepsis and organ system failure are major determinants of post-intensive care unit mortality.
479 Salminen A et al. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging.
480 Salminen A et al. SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation?
481 Salminen A et al. Terpenoids: natural inhibitors of NF-kappaB signaling with anti-inflammatory and anticancer potential.
482 Salminen A et al. Interaction of aging-associated signaling cascades: Inhibition of NF-kappaB signaling by longevity factors FoxOs and SIRT1.
483 Salminen A et al. Amyloid-beta oligomers set fire to inflammasomes and induce Alzherimer's pathology.
484 Salminen A et al. Innate immunity meets with cellular stress at the IKK complex: Regulation of the IKK complex by HSP70 and HSP90.
485 Salminen A et al. NEMO shuttle: a link between DNA damage and NF-kappaB activation in progeroid syndromes?
486 Salminen A et al. ROCK, PAK, and Toll of synapses in Alzheimer's disease.
487 Salonen AJ et al. Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial responce to androgen deprivation.
488 Salonen RO et al. Health risk assessment of indoor air pollution in Finnish ice arenas.
489 Saltevo J et al. Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with insulin sensitivity: a population-based study.
490 Saltevo J et al. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study.
491 Samani NJ et al. Coronary artery disease - associated locus on chromosome 9p21 and early markers of atherosclerosis.
492 Sandini L et al. Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio osteoporosis risk factor and prevention study (OSTPRE).
493 Sankilampi U et al. Congenital Langerhans cell histiocytosis mimicking a "blueberry muffin baby".
494 Saraheimo M et al. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
495 Saraste A et al. Severe coronary artery stenoses and reduced coronary flow velocity reserve in atherosclerotic mouse model Doppler echocardiography validation study .
496 Saukkonen K et al. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock.
497 Savolainen E et al. Serum soluble CD30 in early arthritis: a sign of inflammation but not a predictor of outcome.
498 Savonen K. Heart Rate Response to Exercise in the Prediction of Mortality and Myocardial Infarction. A Prospective Population Study in Men.
499 Savonen KP et al. Chronotropic incompetence and mortality in middle-aged men with known or suspected coronary heart disease.
500 Savonen KP et al. Usefulness of chronotropic incompetence in response to exercise as a predictor of myocardial infarction in middle-aged men without cardiovascular disease.
501 Savonen KP et al. Workload at the heart rate of 100 beats/min and mortality in middle-aged men known or suspected coronary heart disease.
502 Schwab U et al. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism - the GENOBIN study.
503 Seitsonen SP et al. Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration.
504 Seppinen L et al. Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing.
505 Seppälä M et al. Stereotaktinen sädehoito kallon alueelle.
506 Shaw JE et al. Sleep-disordered breathing and type 2 diabetes. A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention.
507 Sierra A et al. Water spin dynamics during apoptotic cell death in glioma gene therapy probed by T1rho and T2rho.
508 Sihto H et al. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
509 Sillanpää E et al. Body composition and fitness during strength and/or endurance training in older men.
510 Silverman SL et al. Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial.
511 Simen-Kapeu A et al. Tobacco smoking and chewing as risk factors for multible human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d´Ivoire and Finland) with different tobacco exposure.
512 Simonen P et al. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes.
513 Sipilä K et al. Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey.
514 Sipilä R et al. Facilitating as a guidelines implementation tool to target resources for high risk patients - The Helsinki Prevention Programme (HPP).
515 Sirola J et al. Grip strength may facilitate fracture prediction in perimenopausal women with normal BMD: a 15-year population-based study.
516 Sivenius J. TIA- ja aivoinfarktipotilaan antitromboottinen lääkehoito.
517 Smirnov G et al. Etoricoxib for pain management during thyroid surgery - a prospective, placebo-controlled study.
518 Smirnov G et al. Silicone tubing is not necessary after primary endoscopic dacryocystorhinostomy: A prospective randomized study.
519 Soimakallio S et al. Kliinisten auditointien toimeenpano 2000-2006 ja auditoinneissa annetut kehittämissuositukset.
520 Soininen H, Hänninen T. Dementoivat sairaudet ja kognitiivinen prosessointi.
521 Soininvaara T et al. Bone mineral density and single photon emission computed tomography changes after total knee arthroplasty: a 2-year follow-up study.
522 Sorvali W et al. Amnionkalvon siirto silmän pintasairauksien hoidossa.
523 Srabstein J et al. Prevention of public health risks linked to bullying: A need for a whole community approach.
524 Staiger H et al. A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study.
525 Stancáková A et al. Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance.
526 Storvik M et al. Correlation between the SERT binding densities in hypothalamus and amygdala in Cloninger type 1 and 2 alcoholics.
527 Suhonen J et al. Hyvät hoitokäytännöt etenevien muistisairauksien kaikissa vaiheissa.
528 Sumanen M et al. Use of quality improvement methods in Finnish health centres in 1998 and 2003.
529 Suomalaisen lääkäriseura Duodecimin ja, Suomen Anestesiologiyhdistys ry:n asettama työryhmä. Leikkausta edeltävä arviointi. Käypä hoito -suositus.
530 Suomalaisen Lääkäriseuran Duodecimin ja et al. Aikuisten epilepsiat.
531 Sutela A. Add-on Stereotactic Core Needle Breast Biopsy. Diagnosis of Non-Palpable Breast Lesions Detected on Mammography or Galactography.
532 Sutela A et al. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.
533 Sutinen P. Pathophysiological Effects of Vibration with Inner Ear as a Model Organ.
534 Suuronen T et al. Regulation of ERalfa signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90.
535 Säisänen L et al. Motor potentials evoked by navigated transcranial magnetic stimulation in healthy subjects.
536 Säisänen L et al. Factors influencing cortical silent period: Optimized stimulus location, intensity and muscle contraction.
537 Taari K et al. Robottiavusteinen prostatektomia eturauhassyövän hoidossa. Järjestelmällinen kirjallisuuskatsaus.
538 Tacke U. Auttavatko masennuslääkkeet todella?
539 Takala J et al. Development and simultaneous application of multiple care protocols in critical care: a multicenter feasibility study.
540 Talasniemi JP et al. Analytical investigation: assay of D-lactate in diabetic plasma and urine.
541 Tammela T et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.
542 Tammi RH et al. Hyaluronan in human tumors: Pathobiological and prognostic messages from cell-associated and stromal hyaluronan.
543 Tapiola T et al. MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.
544 Tarkiainen TH et al. Preoperative alterations in correlation properties and complexity of R-R interval dynamics predict the risk of atrial fibrillation after coronary artery bypass grafting in patients with preserved left ventricular function.
545 Tarkka IM et al. Alterations in cortical excitability in chronic stroke after constraint-induced movement therapy.
546 Taskinen P et al. Aortan tekoläpän asennus katetrin kautta.
547 Tauriainen S et al. Temporal relationship between human parechovirus 1 infektion and otitis media in young children.
548 Teitti S et al. Non-primary motor areas in the human frontal lobe are connected directly to hand muscles.
549 Tervo-Heikkinen T. Hoitotyön vaikuttavuus erikoissairaanhoidossa.
550 Tervo-Heikkinen T et al. Patient satisfaction as a positive nursing outcome.
551 Tervo-Heikkinen T et al. Nurses' work environment and nursing outcomes: A survey study among Finnish university hospital registered nurses.
552 Tervo-Heikkinen T et al. Working conditions of Finnish registered nurses: a national survey.
553 The DREAM Trial Investigators. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose. Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
554 The European Stroke Organisation (ESO), Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008.
555 The Optimising Analysis of Stroke Trials Collaboration. Calculation of sample size for stroke trials assessing functional outcome: comparison of binary and ordinal appoaches.
556 The ORIGIN Trial Investigators. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).
557 Tiihonen J et al. Brain anatomy of persistent violent offenders: more rather than less.
558 Tiihonen M et al. Hormonal contraceptive users' self-reported benefits, adverse reactions, and fears in 2001 and 2007.
559 Tiihonen P et al. A portable device for intensive care brain function monitoring with event-related potentials.
560 Timonen KL et al. Anatomisen ja isotooppikuvantamisen yhdistäminen tarkentaa diagnoosia.
561 Timonen P et al. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.
562 Tolmunen T et al. Dissociation, self-cutting, and other self-harm behavior in a general population of Finnish adolescents.
563 Tolonen N et al. Relationship between lipid profiles and kidney function in patients with type 1 diabetes.
564 Tolppanen A-M et al. The genetic variation of the tenomodulin gene (TNMD) is associated with serum levels of systemic immune mediators - the Finnish Diabetes Prevention Study.
565 Tolppanen A-M et al. The genetic variation in the tenomodulin gene is associated with serum total and LDL cholesterol in a body size-dependent manner.
566 Tukiainen T et al. A multi-metabolite analysis of serum by 1H NMR spectroscopy: Early systemic signs of Alzheimer's disease.
567 Tuomi S. Sairaanhoitajan ammatillinen osaaminen lasten hoitotyössä.
568 Tuomilehto H et al. Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women.
569 Tuomilehto H et al. Sleep-disordered breathing is related to on increased risk for type 2 diabetes in middle-aged men, but not in women - the FIN D2D-survey.
570 Tuomilehto H et al. Headache induced by an arachnoid cyst of the sphenoid sinus: a rare diagnosis problem?
571 Tuomisto TT et al. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2.
572 Tupala E et al. Striatal dopaminergic terminals in type 1 and type 2 alcoholics measured with [3H]dihydrotetrabenazine and human whole himisphere autoradiography.
573 Tupala E, Tiihonen J. Cortical dopamine D1 receptors in type 1 and type 2 alcoholics measured with human whole hemisphere autoradiography.
574 Turunen H et al. Potilasturvallisuuskulttuurin arviointi - kysely erikoissairaanhoidon henkilöstölle.
575 Turunen H et al. Turvallisuuskulttuuria terveydenhuoltoon. Potilasturvallisuus keskeinen haaste.
576 Turunen JHO et al. The public's information needs on analgesics: a descriptive study in a drug information centre.
577 Ungaro P et al. Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II.
578 Usvasalo A et al. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
579 Uusitalo H et al. Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers.
580 Uusitalo L et al. Intake of antioxidant vitamins and trace elements during pregnancy and risk of advanced (beta) cell autoimmunity in the child.
581 Uusitalo L et al. Serum [alpha]- and [gamma]-tocopherol concentrations and risk of advanced beta cell autoimmunity in children with HLA-conferred susceptibility to type 1 diabetes mellitus.
582 Uusitupa M. Genetics or lifestyle - How do we prevent diabetes?
583 Vallittu A-M et al. MxA protein assay for optimal monitoring of IFN-(beta) bioactivity in the treatment of MS patients.
584 Valtonen M et al. Hopelessness - novel facet of the metabolic syndrome in men.
585 Valtonen P et al. Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation.
586 van Gaal FC et al. Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.
587 van Munster CEP et al. Differences in aneurysm and patient characteristics between cohorts of Finnish and Dutch patients with subarachnoid hemorrhage. Time trends between 1986 and 2005.
588 Vanamo K. Closure of a patent ductus arteriosus.
589 Vapalahti M. Comment (to Excellent response to letrozole in brain metastases from breast cancer).
590 Vapalahti M. Comment to (Endonasal endoscopic repair of ethmoid roof cerebrospinal fluid fistula by suturing the dura).
591 Vatanen T et al. Dosimetric verification of a Monte Carlo electron beam model for an add-on eMLC.
592 Vehviläinen-Julkunen K. Järjestelmälliset kirjallisuuskatsaukset näyttöön perustuvan hoitotyön tukena.
593 Vehviläinen-Julkunen K. Tutkimuksen arvioinnit tieteen ja käytäntöjen kehittämisen välineenä.
594 Vehviläinen-Julkunen K. KASTE-ohjelmasta pitkäjänteisyyttä terveydenhuollon ja hoitotyön kehittämiseen.
595 Vehviläinen-Julkunen K. Hoitotieteen aikamatka - määrittelyistä terävään tutkimukseen.
596 Vehviläinen-Julkunen K. Kriitikkona, poliitikkona vai perinteisesti yleistajuistaen - millainen tutkimuksesta tiedottaja olet?
597 Vehviläinen-Julkunen K et al. Tutkimusmetodologia, metodit ja etiikka.
598 Vepsäläinen S et al. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
599 Viinamäki H et al. Partial remission indicates poor functioning and a high level of psychiatric symptoms: a 3-phase 6-year follow-up study on major depression.
600 Viinamäki H et al. Hopelessness and low social and occupational functioning are associated with non-recovery from depression - results of a 6-year follow-up study.
601 Viita H et al. 15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression.
602 Virtanen JO et al. Confirmed primary HHV-6 infection in children with suspected encephalitis.
603 Virtanen T, Kinnunen T. Mammalian allergens.
604 Visser PJ et al. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease.
605 Välimäki T et al. Puoliso-omaishoitajien koherenssin tunne.
606 Väre P et al. Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma.
607 Wadén J et al. Physical activity and diabetes complications in patients with type 1 diabetes. The Finnish Diabetic Nephropathy (FinnDiane) Study.
608 Walldén J et al. No evidence for activation of Thl or Th17 pathways in unstimulated peripheral blood mononuclear cells from children with (beta)-cell autoimmunity or TID.
609 Walldén J et al. Effect of HLA genotype or CTLA-4 polymorphism on cytokine response in healthy children.
610 Wang HH et al. Physiological noise in MR images: An indicator of the tissue response to ischemia?
611 Wang J et al. The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland.
612 Wang Y et al. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.
613 Wehkalampi K et al. Genetic and environmental influences on pubertal timing assessed by height growth.
614 Wehkalampi K et al. Patterns of inheritance of constitutional delay of growth and puberty in families of adolescent girls and boys referred to specialist pediatric care.
615 Wehkalampi K et al. Association of the timing of puberty with a chromosome 2 locus.
616 Westerén-Punnonen S et al. Somatosensory evoked potentials by median nerve stimulation in children during thiopental / sevoflurane anesthesia and the additive effects of ketoprofen and fentanyl.
617 Whincup PH et al. Birth weight and risk of type 2 diabetes: a systematic review.
618 Wikström A, Dunkel L. Klinefelterin oireyhtymään liittyvä hypogonadismi.
619 Wikström AM, Dunkel L. Testicular function in Klinefelter syndrome.
620 Wolfarth B et al. Endothelial nitric oxide synthase gene polymorphism and elite endurance athlete status: the Genathlete study.
621 Zaproudina N et al. Reproducibility of infrared thermography measurements in healthy individuals.
622 Zeggini E et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
623 Zeiler T, Virtanen T. Mapping of human T-cell epitopes of allergens.
624 Zemlin M et al. Regulation of repertoire development through genetic control of Dh reading frame preference.
625 Zhao CS et al. CNS-active drugs in aging population at high risk of cerebrovascular events: Evidence from preclinical and clinical studies.
626 Zhou XW et al. Parallel increase in p70 kinase activation and tau phosphorylation (S262) with Aß overproduction.
627 Zhou XW et al. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
628 Öhman J et al. Paranevatko neurokirurgin huonokuntoiset potilaat?
Kuopion yliopistollinen sairaala Kuopio University Hospital
Julkaisutietokanta 27.8.2009 Publications Data Base 27.8.2009